Biological Information | |
---|---|
Background Information: | PathHunter® U2OS Siglec9 Internalization Cell Line is engineered to co-express the ProLink™ (PK) tagged Siglec9 receptor, and an Enzyme Acceptor (EA) tag localized to the endosomes. Ligand (e.g. Sialic Acid, anti-siglec9 antibody) binding to the receptor stimulates receptor internalization, resulting in colocalization of the receptor-PK with the EA in the endosomes, and forcing complementation of the two β galactosidase (β-gal) enzyme fragments (EA and PK). The resulting functional β-gal enzyme hydrolyzes substrate to generate a chemiluminescent signal. This stable modified cell line is provided as two vials of cryopreserved cells. |
Target Class: | Checkpoint Receptor |
Family: | T cell Receptor (inhibitory) |
Sub Family: | Protein Tyrosine |
Accession Number: | NM_014441.2 |
Target Name: | Siglec9 |
Target Aliases: | Sialic acid-binding Ig-like lectin 9 |
Target Species: | Human |
Cell Background: | U2OS |
Usage | |
Product Type: | Stable Cell Lines |
Application: | Drug Discovery & Development |
Storage Conditions: | Store in vapor phase of liquid nitrogen. |
Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
Assay Information | |
Assay Type: | Functional |
Assay Measures: | Internalization |
Detection Method: | Chemiluminescence |
Additional Information | |
Brand: | PathHunter® |
PathHunter® U2OS Siglec9 Internalization Cell Line
PathHunter® U2OS Siglec9 Internalization Cell Line is engineered to co-express the ProLink™ (PK) tagged Siglec9 receptor, and an Enzyme Acceptor (EA) tag localized to the endosomes. This stable modified cell line is provided as two vials of cryopreserved cells.
User Manuals & Protocols
70-413 PathHunter Internalization Assays User Manual REV0
View DocumentDatasheets
93-1147C3
View Document